8dw1: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 4: Line 4:
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[8dw1]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Moloney_murine_leukemia_virus Moloney murine leukemia virus] and [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8DW1 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8DW1 FirstGlance]. <br>
<table><tr><td colspan='2'>[[8dw1]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Moloney_murine_leukemia_virus Moloney murine leukemia virus] and [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8DW1 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8DW1 FirstGlance]. <br>
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8dw1 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8dw1 OCA], [https://pdbe.org/8dw1 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8dw1 RCSB], [https://www.ebi.ac.uk/pdbsum/8dw1 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8dw1 ProSAT]</span></td></tr>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.849&#8491;</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8dw1 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8dw1 OCA], [https://pdbe.org/8dw1 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8dw1 RCSB], [https://www.ebi.ac.uk/pdbsum/8dw1 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8dw1 ProSAT]</span></td></tr>
</table>
</table>
== Function ==
== Function ==
Line 17: Line 18:
</div>
</div>
<div class="pdbe-citations 8dw1" style="background-color:#fffaf0;"></div>
<div class="pdbe-citations 8dw1" style="background-color:#fffaf0;"></div>
==See Also==
*[[Reverse transcriptase 3D structures|Reverse transcriptase 3D structures]]
== References ==
== References ==
<references/>
<references/>

Latest revision as of 13:15, 25 October 2023

Crystal structure of a host-guest complex with 5'-CTTAGTTATAACTAAG-3'Crystal structure of a host-guest complex with 5'-CTTAGTTATAACTAAG-3'

Structural highlights

8dw1 is a 3 chain structure with sequence from Moloney murine leukemia virus and Synthetic construct. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
Method:X-ray diffraction, Resolution 1.849Å
Resources:FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT

Function

Q8UN00_MLVMO

Publication Abstract from PubMed

Bleomycins constitute a family of anticancer natural products that bind DNA through intercalation of a C-terminal tail/bithiazole moiety and hydrogen-bonding interactions between the remainder of the drug and the minor groove. The clinical utility of the bleomycins is believed to result from single- and double-strand DNA cleavage mediated by the HOO-Fe(III) form of the drug. The bleomycins also serve as a model system to understand the nature of complex drug-DNA interactions that may guide future DNA-targeted drug discovery. In this study, the impact of the C-terminal tail on bleomycin-DNA interactions was investigated. Toward this goal, we determined two crystal structures of HOO-Co(III)*BLMA(2) "green" (a stable structural analogue of the active HOO-Fe(III) drug) bound to duplex DNA containing 5'-TAGTT, one in which the entire drug is bound (fully bound) and a second with only the C-terminal tail/bithiazole bound (partially bound). The structures reported here were captured by soaking HOO-Co(III)*BLMA(2) into preformed host-guest crystals including a preferred DNA-binding site. While the overall structure of DNA-bound BLMA(2) was found to be similar to those reported earlier at the same DNA site for BLMB(2), the intercalated bithiazole of BLMB(2) is "flipped" 180 relative to DNA-bound BLMA(2). This finding highlights an unidentified role for the C-terminal tail in directing the intercalation of the bithiazole. In addition, these analyses identified specific bond rotations within the C-terminal domain of the drug that may be relevant for its reorganization and ability to carry out a double-strand DNA cleavage event.

Two distinct rotations of bithiazole DNA intercalation revealed by direct comparison of crystal structures of Co(III)*bleomycin A(2) and B(2) bound to duplex 5'-TAGTT sites.,Goodwin KD, Lewis MA, Long EC, Georgiadis MM Bioorg Med Chem. 2023 Jan 1;77:117113. doi: 10.1016/j.bmc.2022.117113. Epub 2022 , Dec 6. PMID:36516684[1]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

See Also

References

  1. Goodwin KD, Lewis MA, Long EC, Georgiadis MM. Two distinct rotations of bithiazole DNA intercalation revealed by direct comparison of crystal structures of Co(III)*bleomycin A(2) and B(2) bound to duplex 5'-TAGTT sites. Bioorg Med Chem. 2023 Jan 1;77:117113. doi: 10.1016/j.bmc.2022.117113. Epub 2022 , Dec 6. PMID:36516684 doi:http://dx.doi.org/10.1016/j.bmc.2022.117113

8dw1, resolution 1.85Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA